Papotti M, Pacchioni D, Negro F, Bonino F, Bussolati G
Department of Biomedical Sciences and Oncology, University of Turin, Italy.
Mod Pathol. 1994 Apr;7(3):271-5.
Albumin is a specific product of normal and transformed hepatocytes, but unfortunately its immunohistochemical demonstration proves unreliable because of diffusion artifacts. An in situ hybridization procedure to reveal albumin mRNA was applied to fine needle aspiration specimens of liver nodes with the aim of testing the usefulness of this marker in the cytological diagnosis of hepatocellular carcinomas (HCC). A 51-base pair oligonucleotide probe was labeled with digoxigenin and used on paraffin sections of alcohol-fixed cell blocks. A series of 97 cases originally interpreted, on the basis of cytology alone, as "hepatocellular carcinoma" (62 cases), as "carcinoma cells, not otherwise specified" (15 cases), as "adeno-carcinoma" (16 cases), and as "non-epithelial neoplastic cells" (4 cases), was studied. In all cases, clinical and follow-up information was obtained; a diagnosis of HCC was reached with certainty in 44 cases and suspected in 22. Thirty-one other cases were proven to be bile duct adenocarcinomas or metastatic tumors. Taking into account proven cases only, albumin mRNA was found in 42/44 HCC and in none of the control cases (sensitivity, 95.5%; specificity, 100%). Of 22 cytologically suspected HCC, albumin mRNA was positive in 19 cases. Also, high grade pleomorphic HCCs expressed albumin gene, and this finding is of value in the differential diagnosis with liver metastases of anaplastic tumors from lung, adrenal, pancreas, etc. The diagnosis of HCC on a cytological basis is becoming increasingly important because most cases are unresectable and have to be included in different therapeutic protocols.(ABSTRACT TRUNCATED AT 250 WORDS)
白蛋白是正常肝细胞和转化肝细胞的一种特定产物,但不幸的是,由于扩散假象,其免疫组织化学显示结果并不可靠。为了测试这种标志物在肝细胞癌(HCC)细胞学诊断中的实用性,将一种用于揭示白蛋白mRNA的原位杂交程序应用于肝结节细针穿刺标本。一个51个碱基对的寡核苷酸探针用地高辛标记,并用于酒精固定细胞块的石蜡切片。研究了一系列97例病例,这些病例最初仅根据细胞学分别被解释为“肝细胞癌”(62例)、“未另行指定的癌细胞”(15例)、“腺癌”(16例)和“非上皮性肿瘤细胞”(4例)。在所有病例中,均获取了临床和随访信息;44例确诊为HCC,22例疑似HCC。另外31例被证实为胆管腺癌或转移性肿瘤。仅考虑确诊病例,44例HCC中有42例检测到白蛋白mRNA,而对照病例均未检测到(敏感性为95.5%;特异性为100%)。在22例细胞学疑似HCC中,19例白蛋白mRNA呈阳性。此外,高分级多形性HCC也表达白蛋白基因,这一发现对于与来自肺、肾上腺、胰腺等的间变性肿瘤肝转移进行鉴别诊断具有价值。基于细胞学诊断HCC变得越来越重要,因为大多数病例无法切除,必须纳入不同的治疗方案。(摘要截短于250字)